Krka Group Investor Day 2023 – FY Results & 2024 Guidance

Krka, a leading global generic pharmaceutical company, presents 2023 financial results and 2024 business guidance. The company operates across 70+ markets through 6 sales regions, manufacturing locations worldwide, and serves 55+ million daily patients with affordable medicines.